These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 30703123)
1. Individual response to mTOR inhibition in delaying replicative senescence of mesenchymal stromal cells. Antonioli E; Torres N; Ferretti M; Piccinato CA; Sertie AL PLoS One; 2019; 14(1):e0204784. PubMed ID: 30703123 [TBL] [Abstract][Full Text] [Related]
2. Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107. Khor ES; Wong PF Int J Biochem Cell Biol; 2018 Aug; 101():64-73. PubMed ID: 29857052 [TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism. Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119 [TBL] [Abstract][Full Text] [Related]
4. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway. Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648 [TBL] [Abstract][Full Text] [Related]
5. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence. Luo Y; Li L; Zou P; Wang J; Shao L; Zhou D; Liu L Transplantation; 2014 Jan; 97(1):20-9. PubMed ID: 24092377 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy. Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321 [TBL] [Abstract][Full Text] [Related]
7. Rapamycin and the inhibition of the secretory phenotype. Wang R; Sunchu B; Perez VI Exp Gerontol; 2017 Aug; 94():89-92. PubMed ID: 28167236 [TBL] [Abstract][Full Text] [Related]
8. Fluorofenidone inhibits UV-A induced senescence in human dermal fibroblasts via the mammalian target of rapamycin-dependent SIRT1 pathway. Lei D; Huang Y; Xie H; Yi Y; Long J; Lin S; Huang C; Jian D; Li J J Dermatol; 2018 Jul; 45(7):791-798. PubMed ID: 29726032 [TBL] [Abstract][Full Text] [Related]
9. miR-29c-3p promotes senescence of human mesenchymal stem cells by targeting CNOT6 through p53-p21 and p16-pRB pathways. Shang J; Yao Y; Fan X; Shangguan L; Li J; Liu H; Zhou Y Biochim Biophys Acta; 2016 Apr; 1863(4):520-32. PubMed ID: 26792405 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells. Park JH; Lee NK; Lim HJ; Ji ST; Kim YJ; Jang WB; Kim DY; Kang S; Yun J; Ha JS; Kim H; Lee D; Baek SH; Kwon SM Exp Mol Med; 2020 Apr; 52(4):615-628. PubMed ID: 32273566 [TBL] [Abstract][Full Text] [Related]
11. Rapamycin, proliferation and geroconversion to senescence. Blagosklonny MV Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374 [TBL] [Abstract][Full Text] [Related]
12. 5-methoxytryptophan protects MSCs from stress induced premature senescence by upregulating FoxO3a and mTOR. Chang TC; Hsu MF; Shih CY; Wu KK Sci Rep; 2017 Sep; 7(1):11133. PubMed ID: 28894133 [TBL] [Abstract][Full Text] [Related]
14. High glucose induces the aging of mesenchymal stem cells via Akt/mTOR signaling. Zhang D; Lu H; Chen Z; Wang Y; Lin J; Xu S; Zhang C; Wang B; Yuan Z; Feng X; Jiang X; Pan J Mol Med Rep; 2017 Aug; 16(2):1685-1690. PubMed ID: 28656269 [TBL] [Abstract][Full Text] [Related]
15. Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16. Sung JY; Lee KY; Kim JR; Choi HC Exp Gerontol; 2018 Aug; 109():51-58. PubMed ID: 28797827 [TBL] [Abstract][Full Text] [Related]
16. Culturing on Wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways. Hao H; Chen G; Liu J; Ti D; Zhao Y; Xu S; Fu X; Han W PLoS One; 2013; 8(3):e58314. PubMed ID: 23516461 [TBL] [Abstract][Full Text] [Related]
17. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors. Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484 [TBL] [Abstract][Full Text] [Related]
18. An early-senescence state in aged mesenchymal stromal cells contributes to hematopoietic stem and progenitor cell clonogenic impairment through the activation of a pro-inflammatory program. Gnani D; Crippa S; Della Volpe L; Rossella V; Conti A; Lettera E; Rivis S; Ometti M; Fraschini G; Bernardo ME; Di Micco R Aging Cell; 2019 Jun; 18(3):e12933. PubMed ID: 30828977 [TBL] [Abstract][Full Text] [Related]
19. Rapamycin, a mTOR inhibitor, induced growth inhibition in retinoblastoma Y79 cell via down-regulation of Bmi-1. Wang YD; Su YJ; Li JY; Yao XC; Liang GJ Int J Clin Exp Pathol; 2015; 8(5):5182-8. PubMed ID: 26191215 [TBL] [Abstract][Full Text] [Related]